Cryoport (CYRX) Misses Q4 EPS by 98c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq futures slide as Alphabet results intensify AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
- ServiceNow (NOW) Misses Q3 EPS by 2c, Beats on Revenue; Offers Q4 Revenue Guidance
- Oracle sets $225 billion revenue target for FY30 at investor day
- Rivian shares slip ahead of Thursday earnings release
- Marvell in advanced talks to acquire Lumentum, Bloomberg reports
- Moderna stock rises on latest cancer vaccine data publication
CryoPort (CYRX) PT Lowered to $18 at Needham
March 13, 2024 6:36 AM EDTNeedham analyst David Saxon lowered the price target on CryoPort (NASDAQ: CYRX) to $18.00 (from $19.00) while maintaining a Buy rating.
The analyst comments "CYRX's 4Q23 revenue missed consensus and management provided 2024 revenue guidance below consensus. Importantly, management believes MVE has stabilized and expects... More



